Revvity, Inc. (NYSE:RVTY) stock rose Tuesday after the life sciences and diagnostics company released preliminary expectations for the fourth quarter and fiscal year 2025.
The positive movement comes despite broader market pressure, with major indices like the Nasdaq and S&P 500 both slightly down. The broader market is experiencing a mixed day, with the Nasdaq down 0.19% and the S&P 500 falling 0.20%.
The company announced that it will release its fourth-quarter and full-year 2025 financial results on February 2, 2026.
RVTY Q4 Prelim Earnings: 6% Revenue Growth
Preliminary expectations indicate reported revenue growth of approximately 6% for the fourth quarter to approximately $772 million, compared to the consensus of $760.6 million, with full-year revenue projected to reach around $2.855 billion, reflecting a growth rate of about 4% year-over-year compared to the consensus of $2.84 billion.
Revvity …